Webinars

Biocidal active substances are called in situ generated active substances if they are generated from one or more precursors at the place of use. The approval of these substances requires evaluation of the generated active substance and of the precursor(s) it is generated from, in the context of each product type (PT).

All biocidal products must comply with certain regulatory provisions before being placed on the European market (Biocidal Products Regulation 528/2012). They depend on the status of the active substance, the product type (PT) and the Member State(s) in which the biocidal product will be made available.

After Brexit on 31 January 2020, the UK entered a time limited transition period until 31st of December 2020. As the transition period has ended, regulation is an autonomous matter for both the UK and the EU as 2 separate legal and regulatory systems.

Companies must register substances and, in order to do so, collaborate with other companies that register the same substances. In this webinar, we will review the principles of REACH registration, explaining the scope, progress and obligations in the supply chain.

In this webinar, we will first discuss the requirements applicable to e-liquids. Then, we will present an overview of the different actors in the supply chain and their obligations. We will finally walk you through the key steps for notifying mixtures and processing a PCN notification for e-liquids.

In Europe, food supplements must comply with European Directive 2002/46/EC as well as any local legislation in each country